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Oyster-derived polysaccharides (OPS) have been shown to modulate the T helper (Th)1/Th2
immunobalance toward the Th1-dominant direction in antigen-primed splenocytes. In the
present study, we hypothesized that OPS might attenuate intestinal inflammation asso-
ciated with food allergy, a Th2-dominant immune disorder. BALB/c mice were sensitized
twice with ovalbumin (OVA) absorbed to alum and then repeatedly challenged with
intragastric OVA to induce intestinal allergic responses. The mice were administered by
gavage with OPS and/or vehicle (distilled water) once/d during the two sensitization pha-
ses, and once every other day during the challenge phase. Administration with OPS
attenuated OVA challenge-elicited diarrhea, and the infiltration of mast cells in the in-
testine. OPS demonstrated a protective effect on the reduced ratio of villus length over
crypt depth of the intestine in allergic mice. Furthermore, OPS administration markedly
attenuated the intestinal expression of the Th2 signature cytokine interleukin-4 (IL-4).
Collectively, these results demonstrated the in vivo antiallergic activity of OPS, which is
associated with the suppression of allergen-induced intestinal Th2 responses and mast cell
activation.
Copyright © 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The Pacific oyster Crassostrea gigas (Thunberg) is a common
seafood widely cultured in the Penghu islands and Taiwan's
coastal areas. Previous reports suggest that the Pacific oysteraduate Institute of Veteri
. Jan).
s work.
inistration, Taiwan. Publis
/licenses/by-nc-nd/4.0/).is of nutritional value, as it contains amino acids, carbohy-
drates, lipids, minerals, polyunsaturated fatty acids, and
proteins [1,2]. In addition, functional studies demonstrated
that constituents of the Pacific oyster exhibited a number of
potential health-promoting properties, including anti-
hyperlipidemia, antioxidation, and immunomodulation [3e6].nary Medicine, National Taiwan University, Number 1, Section 4,
hed by Elsevier Taiwan LLC. This is an open access article under the CC
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the immunomodulatory effect of the oyster-derived poly-
saccharides (OPS) on antigen-specific immune responses.
Direct exposure of ovalbumin (OVA)-primed murine spleno-
cytes to OPS enhanced the cell metabolic activity and prolif-
eration, and the expression of T helper (Th)1 signature
cytokine and transcription factor, namely interferon (IFN)-g
and T-bet, respectively. By contrast, OPS attenuated the
expression of the Th2 cell-related cytokine interleukin (IL)-4
[7]. OPS-mediated Th1-enhancing effects were further
confirmed in vivo, as evidenced by the upregulation of IFN-g
production and T-bet mRNA expression in splenocytes iso-
lated from mice sensitized with OVA and administered with
OPS. Together these results demonstrate the immunomodu-
latory effects of OPS on T cell responses, in which the T cell
immunobalance was skewed to the Th1-dominant direction.
Food allergy is an immunological disorder to various di-
etary proteins. Common food allergens include eggs, milk,
peanuts, shellfishes, and tree nuts [8,9]. Hypersensitivity re-
actions associatedwith food allergymay range frommoderate
gastrointestinal disturbance to life-threatening anaphylaxis
[10,11]. Currentmanagement of food allergyprimarily relies on
allergen avoidance. Effectiveness of symptomatic pharmaco-
therapy is limited to mainly control inflammatory responses
associated with allergic attacks [12]. The immunopathology of
food allergy is characterized by an aberrant T cell immuno-
balance to dietary allergens, in which the differentiation of
antigen-specific Th cells is skewed to the Th2 phenotype [13].
IL-4, the signature cytokine expressed by Th2 cells, is a key
mediator promoting the maturation of mast cells that is
responsible for triggering hypersensitivity reactions [14].
On the basis of our previous results showing that OPS
modulated the T cell immunobalance toward the Th1-
dominant direction in OVA-primed splenocytes, and pro-
moted Th1-type immunity in OVA-sensitized mice [7], we
hypothesized that OPS might be effective in modulating food
allergy, a predominantly Th2-type immune disorder. We
report here that oral administration with OPS attenuates in-
testinal allergic inflammation associated with food allergy.Fig. 1 e Protocols of oyster-derived polysaccharides (OPS)
administration and ovalbumin (OVA) sensitization and
challenge. BALB/c mice were randomly divided into five
groups (5e6 mice/group) as described in the figure. The
mice in the VH, O-50, and O-200 groups were administered
daily OPS (50 mg/kg or 200 mg/kg) and/or VH (distilled
water; D.W.) for five doses during the sensitized phase, and
once every other day for six doses during the challenge
phase. Except for the NS group (untreated, nonsensitized
but OVA-challenged), the mice were sensitized by an
intraperitoneal injection of OVA and alum on Day 3 and
boosted on Day 17. To induce allergic diarrhea, the mice
were repeatedly challenged with OVA by gavage every
other day from Day 31 to Day 41. For histological
examination, all mice were sacrificed 3 hours after the last
OVA challenge on Day 41.2. Methods
2.1. Reagents
All reagents and chemicals were purchased from Sigma
Chemicals (St. Louis, MO, USA) unless otherwise described.
Anti-mouse IL-4 rat immunoglobulin G1 (IgG1) was purchased
from BioLegend (San Diego, CA, USA). Reagents used for
immunohistochemical (IHC) staining were purchased from
AbCam Inc. (Cambridge, MA, USA) and BioGenex Laboratories
(San Ramon, CA, USA).
2.2. Preparation of OPS
The OPS used in the present study was extracted from fresh
oysters (C. gigas). After drying and weighing, the oysters were
incubated with hot water at 80C for 4 hours, cooled down to
room temperature (RT), and then centrifuged. The superna-
tant was mixed with an equal volume of 95% ethanol toprecipitate polysaccharides. After centrifuging at 12,000 g for
30minutes, the pellet was collected and freeze-dried to obtain
OPS. TheOPS contained 238.2 g of b-glucans/kg, as determined
by measuring its nondigestible portion to a-glucosidase. The
molecular weight of OPS has been determined to be approxi-
mately 435 kDa. The amount of glucose and protein in OPS
was also determined to be 979.8 g/kg and <20.0 g/kg, respec-
tively, confirming the purity of OPS.2.3. Animals
Male BALB/c mice, 4e6 weeks of age, were obtained from
BioLasco (Ilan, Taiwan). On arrival, mice were randomized,
transferred to plastic cageswith a sawdust bedding (5e6mice/
cage) and quarantined at least for 1 week before experimen-
tation. The mice were given standard laboratory food and
water ad libitum, except for the days receiving OVA challenge
(described below). The animal room was maintained at the
temperature of 25 ± 2C and a relative humidity of 50 ± 20%,
with a 12 hour light/dark cycle.2.4. Protocol of animal experiments
A previously described murine model of food allergy induced
by OVA was employed [15,16]. BALB/c mice were randomly
divided into the following five groups (5e6 mice/group; Fig. 1):
(1) NS group: untreated, nonsensitized but OVA-challenged;
(2) OVA group: untreated but OVA-sensitized and chal-
lenged; (3) VH group: vehicle-treated (distilled water; 0.1 mL/
mouse) and OVA-sensitized and challenged; (4) O-50 group:
Fig. 2 e Oyster-derived polysaccharides (OPS) attenuated
the occurrence of allergic diarrhea. Mice were treated as
described in Fig. 1. Allergic diarrhea was visually
monitored for 3 hours after every challenge. Mice
demonstrating profuse liquid stools were recorded as
diarrhea positive animals. Results are pooled samples
from eight independent experiments (n ¼ 35e40). *p < 0.05
compared to the VH group [vehicle-treated (distilled water;
0.1 mL/mouse)]. NS ¼ nonsensitized; OVA ¼ ovalbumin;
VH ¼ vehicle.
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and challenged; and (5) O-200 group: (200 mg/kg; 0.1 mL/
mouse) and OVA-sensitized and challenged. Except for the NS
group, the mice were sensitized by an intraperitoneal injec-
tion of 50 mg OVA absorbed to 1 mg alum on Day 3, and then
boosted with a double dose on Day 17. To induce allergic re-
sponses, the mice were repeatedly challenged with OVA
(50 mg/0.3 mL in saline/mouse) by gavage every other day
fromDay 31 to Day 41. Before each intragastric OVA challenge,
mice were deprived of food for 3 hours. Allergic diarrhea was
visually monitored for 3 hours after challenge. Mice demon-
strating profuse liquid stools were recorded as diarrhea-
positive animals. The diarrheal occurrence (%) was calcu-
lated according to the following formula:
diarrheal occurrence (%) ¼ (the number of diarrhea-positive
mice in each group/the number ofmice in each group) 100%.
OPS and/or VH (distilled water) were administered by
gavage once/d during the two sensitization phases from Day 1
to Day 5 and from Day 15 to Day 19, and once every other day
during the challenge phase from Day 30 to Day 40. The dosing
of OPS on alternate days during the challenge phase avoided
delivering OPS and OVA on the same day. The dose of OPSwas
chosen according to our previous results showing the immu-
nomodulatory activity of OPS in OVA-sensitized mice [7]. For
histological examination, all mice were sacrificed 3 hours
after the last OVA challenge on Day 41. The animal experi-
ments were approved by the Institutional Animal Care and
Use Committee of the National Taiwan University, Taipei,
Taiwan.
2.5. Necropsy and intestinal tissue preparation
The duodenum was excised and fixed in 10% neutral buffered
formalin for 24 hours. The tissues were embedded in paraffin
and cut into 4e5 mm sections that were stained with
hematoxylin-eosin (H&E) and toluidine blue for routine his-
topathology and identification of mast cells, respectively.
Tissue sections were also subjected to IHC staining for the
detection of IL-4.
2.6. IHC staining
The tissue sectionswere first deparaffinized by immersing the
slides in xylene for 5 minutes three times at RT. The slides
were rehydrated by immersing sequentially in 100%, 95%,
90%, 80%, and 60% ethanol for 5 minutes each, and then
washed three times with 1 Tris-based solution (TBS) for 5
minutes at RT. The rehydrated slides were immersed in Tril-
ogy at 121C for 15 minutes for antigen retrieval. The slides
were then immersed in preheated Trilogy at 80C for 10 mi-
nutes and cooled down immediately in 1 TBS for 10minutes.
The endogenous peroxidase activity was quenched with 3%
H2O2 in methanol for 10 minutes at RT, then washed with 1
TBS and blocked with normal goat serum for 1 hour at RT in
the dark. All of the following operations were placed in the
dark. The anti-mouse IL-4 monoclonal antibody was applied
on to each section overnight at 4C. After washing, slides weretreated with super enhancer for 1 hour at RT, and then incu-
bated with poly-horseradish peroxidase (HRP) reagent for 1
hour at RT. For visualization, slides were treated with the HRP
substrate 3-amino-9-ethylcarbazole followed by hematoxylin
counter staining for an appropriate time at RT. Slides were
visualized under a light microscope.2.7. Morphometric analysis and IHC staining
quantification
The villus length and crypt depth on H&E stained slides were
measured using the Image-Pro Plus version 5.1 morphometric
analysis software (Media Cybernetics, Inc., Silver Spring, MD,
USA). The number of mast cells was counted manually after
stainingwith toluidine blue. The number of IL-4þ cells (the red
color) was identified in contrast to the background counter
stain (the blue color) using Image-Pro Plus version 5.1
morphometric analysis software (Media Cybernetics, Inc.).
Three measurements/tissue section and 4e6 sections/group
were analyzed at 200-fold magnification.2.8. Statistical analysis
Data of diarrhea occurrence were expressed as a percentage
and analyzed using the Chi-square test to compare the dif-
ference between the OPS-treated group and the VH control. All
other quantitative data are expressed as the mean ± standard
error for each experimental group. The student t test was used
to analyze the statistical difference between the treatment
groups (OPS) and control group (VH). A p value < 0.05 was
defined as statistical significance.
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3.1. OPS attenuated the occurrence of allergic diarrhea
We first examined the effect of OPS on the occurrence of
allergic diarrhea in mice with a food allergy. As expected,
allergic diarrhea was successfully induced in all of the OVA-
sensitized mice, but not in the NS group. The rate of diar-
rhea reached 100% following the sixth OVA challenge in the
OVA and VH groups (Fig. 2). Administration with OPS (50 mg/
kg and 200 mg/kg) partially, but significantly attenuated the
occurrence of diarrhea from the fourth to the sixth OVA
challenge. Both doses of OPS showed a comparable effect, inFig. 3 e Oyster-derived polysaccharides (OPS) restored the dimi
duodenum. Mice were treated as described in Fig. 1. Tissue secti
eosin (H&E) staining. The villus length and crypt depth were me
analysis software (100£ field; Media Cybernetics, Inc., Silver Sp
error of 27-1 samples per group pooled from six independent e
treated (distilled water; 0.1 mL/mouse)]. NS ¼ nonsensitized; Owhich the diarrhea rate in OPS-treated groups was approxi-
mately 30% less than that in the VH group (Fig. 2). In addition,
OPS administration neither altered the body weight of mice
nor induced obvious gross lesions at necropsy (data not
shown), suggesting that the employed dosing regimens were
safe to the animals.
3.2. Effect of OPS on morphologic alterations of the
duodenum of allergic mice
The above results showed that OPS attenuated the occurrence
of allergic diarrhea.We next examined the influence of OPS on
the duodenal morphology using histological examination.
Results from H&E staining showed irregular shapes of the villinished ratio of villus length over crypt depth in the
ons of duodenumwere prepared for standard hematoxylin-
asured using the Image-Pro Plus version 5.1 morphometric
ring, MD, USA). Data are expressed as the mean ± standard
xperiments. *p < 0.05 compared to the VH group [vehicle-
VA ¼ ovalbumin.
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(Fig. 3), demonstrating the alterations of normal duodenal
morphology associated with food allergy. To quantify the al-
terations, the villus length and crypt depth were measured
and the ratio of villus/crypt was calculated. Compared to the
NS group, the ratio was significantly reduced in allergic mice
(Fig. 3; OVA vs. NS). Administration with OPS (50 mg/kg and
200 mg/kg) prevented the morphologic changes, and restored
the reduced villus/crypt ratio (Fig. 3; OPS vs. VH).
3.3. Effect of OPS on the infiltration and degranulation
of mast cells in the duodenum
Inflammatory mediators released by mast cells are respon-
sible for triggering inflammatory symptoms in type IFig. 4 e Effect of oyster-derived polysaccharides (OPS) on the in
Fig. 1. Tissue sections of duodenum were stained with toluidin
cells (red arrows) was counted under 200£ field. Data are expre
pooled from six independent experiments. *p < 0.05 compared
mouse)]. NS ¼ nonsensitized; OVA ¼ ovalbumin; VH ¼ vehicle.hypersensitivity. The infiltration of mast cells in the duo-
denum was examined using toluidine blue staining. Both
doses of OPS (50 mg/kg and 200 mg/kg) significantly attenu-
ated the number of infiltrated mast cells (Fig. 4).
3.4. Effect of OPS on the infiltration of IL-4þ cells in
duodenum
Th cells play a pivotal role in the immunopathology of type I
hypersensitivity such as food allergy. To scrutinize the effect
of OPS on the functionality of Th cells in the inflammatory
site, we examined the duodenal expression of IL-4, a Th2
signature cytokine. The number of IL-4þ cells in the duo-
denumwasmarkedly elevated in the OVA group, compared to
the NS group, confirming the Th2 profile of food allergy. Thefiltration of mast cells. Mice were treated as described in
e blue for identification of mast cells. The number of mast
ssed as the mean ± standard error of 32 samples per group
to the VH group [vehicle-treated (distilled water; 0.1 mL/
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allergic mice administered with OPS (Fig. 5; OPS vs. VH).4. Discussion
Polysaccharides, in particular b-glucans, exhibit immuno-
modulatory activities that may be beneficial for the man-
agement of allergic disorders. For example, intake of b-
glucans decreased the level of IL-4 and IL-5 and the eosino-
phil count in the nasal lavage fluid of patients with allergic
rhinitis [17]. b-Glucans purified from Aureobasidium pullulansFig. 5 e Effect of oyster-derived polysaccharides (OPS) on the in
were treated as described in Fig. 1. Immunohistochemical (IHC
duodenum. The image was analyzed and the positive signal (the
5.1 morphometric analysis software (200£ field; Media Cyberne
mean ± standard error of 20e22 samples per group pooled from
VH group [vehicle-treated (distilled water; 0.1 mL/mouse)]. NS ¼attenuated food allergic reactions in a murine model of food
allergy [18]. Based on our previous results showing that OPS
modulated the Th1/Th2 immunobalance toward the Th1-
dominant direction [7], the present study investigated the
potential antiallergic effect of OPS in a murine model of food
allergy. In this model, OVA-sensitized mice were repeatedly
challenged with OVA by gavage to induce allergic diarrhea
and intestinal inflammation. Our results showed that OPS
administration partially, but significantly attenuated the
occurrence of allergen-induced diarrhea. To the best of our
knowledge, the present study provides the first evidence to
show that polysaccharides extracted from the commonfiltration of interleukin-4 (IL-4)þ cells in duodenum. Mice
) staining was performed to detect IL-4þ cells in the
red color) was quantified using the Image-Pro Plus version
tics, Inc., Silver Spring, MD, USA). Data are expressed as the
four independent experiments. *p < 0.05 compared to the
nonsensitized; OVA ¼ ovalbumin; VH ¼ vehicle.
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responses.
Histological examination was employed to investigate
the antiallergic effect of OPS against intestinal inflamma-
tion. The shape of villi became irregular, and the crypts
showed hyperplasia in allergic mice, resulting in a
decreased ratio of the villus length over the crypt depth. In
allergic mice administered with OPS, the degree of hyper-
plasia of crypts was reduced, and the ratio of villus/crypt
was restored. These results clearly demonstrated that in line
with the attenuation of allergic diarrhea, administration
with OPS exhibited a protective effect on the morphologic
alterations associated with allergic inflammation in the
intestine.
To further investigate the effect of OPS on allergic inflam-
mation, the duodenal sections were stained with toluidine
blue for detection of mast cells. The number of mast cells was
markedly increased in the duodenum of allergic mice, con-
firming the infiltration of mast cells in the inflamed site of
allergy. Notably, the infiltration of mast cells was attenuated
by the treatment with OPS. More importantly, both doses of
OPS significantly reduced the number of infiltrated mast cells.
It is well known that inflammatory mediators released by
mast cells trigger allergic reactions. Hence, our results suggest
that OPS may be potentially used to alleviate mast cell-
mediated inflammatory disorders such as food allergy.
Further studies using other appropriate models of inflamma-
tion are warranted to address this notion.
It is well established that allergen-primed Th2 cells are
critical for the development of type I hypersensitivity [19]. We
therefore examined in the duodenum the expression of IL-4, a
signature Th2 cytokine. Consistent with the Th2 nature of the
food allergy model [20], the number of IL-4þ cells was mark-
edly increased in allergic mice. Administration with OPS
significantly decreased the number of IL-4þ cells, suggesting
that OPS-mediated attenuation of allergic inflammation
might be mediated by a reduced activation of Th2 cells in the
inflammatory site. Furthermore, these results confirm our
hypothesis that OPS possesses immunomodulatory activities
against Th2 cell-mediated allergic reactions. Notably, the
antiallergic effects between the two doses of OPS were com-
parable, implying that OPS at a dose greater than 50 mg/kg
might reach a plateau on the allergen-induced intestinal
inflammation. It is possible that dosages lower than 50 mg/kg
may be effective against food allergy, which warrants further
investigation.
Collectively, the present study demonstrated the in vivo
antiinflammatory activities of OPS against food allergy,
including the attenuation of allergic diarrhea, the protection
of the duodenal morphology, and the suppression of mast cell
and Th2 cell functionality. Results from the present study
suggest a potential for OPS to be exploited as a functional
natural product for the management of Th2-dominant disor-
ders, such as food allergy.Conflicts of interest
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